Bayer Yaz and Yasmin Lawsuit Settlements Climb to $142 Million

Published April 26, 2012 by Bloomberg Bayer AG (BAYN) said settlements of U.S. lawsuits claiming that its Yasmin line of birth-control pills caused blood clots in women have increased to $142 million. Bayer, based in Leverkusen, Germany, has resolved 651 cases alleging its Yasmin and Yaz contraceptives caused sometimes- fatal clots that can lead to  Full Article…

Comments Off

New Yaz and Yasmin Lawsuits Filed in New Jersey

Published May 15, 2012 on Seedol Yaz Lawsuit Filed in New Jersey 05/15/2012: A new Yaz Lawsuit was filed in the United States District Court, D. New Jersey on or about April 30th, 2012 against Bayer Healthcare Pharmaceuticals, Inc., Berlex Laboratories, Inc., Berlex, Inc., Bayer Pharma Ag, Bayer Ag, Jane Doe Distributors on behalf of  Full Article…

Comments Off

Yaz and Yasmin Lawsuits

Published May 19, 2012 on Seedol In addition to the nearly 12,000 Yaz and Yasmin Lawsuits that have been filed a new Yaz Lawsuit and Yasmin Lawsuit was filed in the Superior Court of California, Los Angeles County in late April. This new Y Lawsuit names Bayer Healthcare LLC; Bayer Pharmaceuticals Corporation; Bayer Healthcare Pharmaceuticals  Full Article…

Comments Off

Boston Scientific Faces Nearly 300 Lawsuits So Far Over Problems With Mesh Implants

Published May 5, 2012 on Mass. Market When Sheila Roach was admitted for surgery in May 2008 to treat pelvic discomfort and urinary incontinence, she had no idea that the solution would be more painful than the problem. But that’s exactly what Roach says happened, based on the lawsuit she filed against Boston Scientific on  Full Article…

Comments Off

New Lawsuit on Zimmer Durom Cup: Adverse Events

Published May 8, 2012 on PR Web According to court documents, on March 15th, 2012, a California resident, Therese Gonzales, filed a lawsuit in New Jersey District Court (case no. 2:2012cv01651) against Zimmer Inc. alleging that Zimmer Durom Cup was defectively designed and caused her pain and side effects that “are consistent with loosening of  Full Article…

Comments Off

Some Previously Approved Medical Devices are Skirting Past FDA Evaluation

Published May 8, 2012 on TMD A loophole in federal law requires the FDA to approve some previously-recalled medical devices. Now, the agency says it wants to see that changed. Defective hip implant devices and transvaginal mesh devices went to market despite significant concerns over the safety of earlier models. In addition, thousands of Americans  Full Article…

Comments Off

Yaz Settlements Reach into Millions

Published May 7, 2012 on Injury Lawyer News Settlements for plaintiffs who have experienced serious side effects associated with the popular birth control medications Yaz and Yasmin have reached into the millions, after hundreds of plaintiffs received Yaz side effects settlements recently. Yaz drug maker Bayer has agreed to pay out at least $110 million  Full Article…

Comments Off

Judge Extends Yaz Lawsuit Deadlines to Allow More Settlements

Published May 7, 2012 on drugwatch A judge overseeing the multidistrict litigation (MDL) regarding the oral contraceptive Yaz has cleared the way for more settlement negotiations to continue. Chief Judge David R. Herndon, of the U.S. District Court for the Southern District of Illinois, moved back the deadlines for Yaz lawsuits, allowing for the drug’s  Full Article…

Comments Off

Distributor Removed from Zoloft Lawsuit

Published April 20, 2012 on Injury Lawyer News A distributor of Zoloft has been removed from a California lawsuit that alleges the drug caused Zoloft birth defects in her son. The Court of the Central District of California ruled that plaintiffs Lisa and Jacob Gray did not provide sufficient evidence to prove that the drug  Full Article…

Comments Off

Abbott to Pay $1.6B to Settle Depakote Claims

Published May 7, 2012 by Chicago Tribune Abbott Laboratories said Monday it will pay $1.6 billion to settle federal and state claims that it illegally marketed the anti-seizure medication Depakote for uses not approved by the Food and Drug Administration. As part of the settlement agreement, North Chicago-based Abbott said it would pay $800 million  Full Article…

Comments Off